Addictive Painkiller Prescribed to Patients Who Shouldn’t Have Received It
Another disturbing story about the opioid crisis:
According to a former employee of Insys Therapeutics, their drug, Subsys, was prescribed to many patients who shouldn’t have received it. Subsys is a fentanyl sublingual spray designed to relieve cancer pain, and many of those who received the drug did not have cancer. The whistleblower says that she was part of the company’s plan to get the highly addictive drug into the hands of people who didn’t need it.
“My job responsibilities were to contact insurance companies on behalf of the patients and the doctors to get the medication approved and paid for by their insurance company,” she told NBC.
Nixon told NBC that her supervisor told her ways to trick the insurers into believing it was “medically necessary.”
“I would say, ‘Hi, this is Patty. I’m calling from Dr. Smith’s office. I’m calling to request prior authorization for a medication called Subsys,'” she told McFadden. Nixon says she would also mention oncology records that didn’t exist and provide insurance companies with specific diagnosis codes, whether or not the patients had those conditions.
To read the full story from NBC News, click here.